Malignant melanoma (metastatic)

door Larkin, James, Gore, Martin
Gepubliceerd in 2008

Renal Cell Cancer: What Can We Learn from Pre-Operative Studies?

door Fisher, Rosalie, Larkin, James
Gepubliceerd in 2011

Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma

door Fisher, Rosalie, Larkin, James
Gepubliceerd in 2012

Individualising treatment choices in a crowded treatment algorithm

door Fisher, Rosalie, Larkin, James
Gepubliceerd in 2013

Renal cell carcinoma and the use of sorafenib

door Larkin, James MG, Eisen, Tim
Gepubliceerd in 2006

Malignant melanoma (metastatic)

door Fisher, Rosalie Anne, Larkin, James
Gepubliceerd in 2010

Adrenal insufficiency and checkpoint inhibitors for cancer

door Morganstein, Daniel L, Larkin, James
Gepubliceerd in Clin Med (Lond) (2020)

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib

door Vasudev, Naveen S., Larkin, James M.G.
Gepubliceerd in 2011

Inter and Intratumour Heterogeneity: A Barrier to Individualized Medical Therapy in Renal Cell Carcinoma?

door Fisher, Rosalie, Larkin, James, Swanton, Charles
Gepubliceerd in 2012

Delivering preventive, predictive and personalised cancer medicine for renal cell carcinoma: the challenge of tumour heterogeneity

door Fisher, Rosalie, Larkin, James, Swanton, Charles
Gepubliceerd in 2011

Experience with sunitinib in the treatment of metastatic renal cell carcinoma

door Schmidinger, Manuela, Larkin, James, Ravaud, Alain
Gepubliceerd in 2012

Renal cell carcinoma. Translational biology, personalized medicine and novel therapeutic targets

door Vasudev, Naveen S, Larkin, James M G
Gepubliceerd in 2013

New survival standards for advanced melanoma

door Spain, Lavinia, Larkin, James, Turajlic, Samra
Gepubliceerd in Br J Cancer (2020)

Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm

door Khattak, Muhammad, Fisher, Rosalie, Turajlic, Samra, Larkin, James
Gepubliceerd in 2013

Immune-checkpoint inhibitors in melanoma and kidney cancer: from sequencing to rational selection

door Flynn, Michael, Pickering, Lisa, Larkin, James, Turajlic, Samra
Gepubliceerd in Ther Adv Med Oncol (2018)

Future career intentions of recent GP graduates in Ireland: a trend analysis study

door Pericin, Ivana, Mansfield, Gerard, Larkin, James, Collins, Claire
Gepubliceerd in BJGP Open (2018)

What is the risk of intracranial bleeding during anti-VEGF therapy?

door Carden, Craig P., Larkin, James M.G., Rosenthal, Mark A.
Gepubliceerd in 2008

Fatigue in Renal Cell Carcinoma: The Hidden Burden of Current Targeted Therapies

door Larkin, James M.G., Pyle, Lynda M., Gore, Martin E.
Gepubliceerd in 2010

Translational Implications of Tumor Heterogeneity

door Jamal-Hanjani, Mariam, Quezada, Sergio A., Larkin, James, Swanton, Charles
Gepubliceerd in Clin Cancer Res (2015)

The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK

door Larkin, James, Hatswell, Anthony J., Nathan, Paul, Lebmeier, Maximilian, Lee, Dawn
Gepubliceerd in PLoS One (2015)